B Cell News and Research

RSS

Deep Genomics receives $13 million investment to create new class of genetic drugs

Deep Genomics, the AI driven genetic medicine company, received a USD $13 million equity investment led by Khosla Ventures, one of the top venture capital firms. They are accompanied by early stage investment firm True Ventures.

28 Sep 2017

Surgical screws being developed from donated human bone material

Biomechanics from TU Graz, are developing surgical screws from donated human bone material for foot and jaw surgery together with surgebright, a start-up from Linz, Austria.

28 Sep 2017

DuraClone RE antibody panels improve detection of rare, abnormal events in blood disorders

Beckman Coulter Life Sciences has taken the detection of rare, abnormal events in blood disorders forward, with intro of antibody panels.

From Beckman Coulter Life Sciences - Flow Cytometry 28 Sep 2017

Researchers test way to stop or slow cardiac fibrosis after heart injury

Early research results suggest scientists might be on to a way to preserve heart function after heart attacks or for people with inherited heart defects called congenital cardiomyopathies.

28 Sep 2017

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Osaka Researchers, in partnership with other Japanese and U.S. scientists, report a new gene target, KPNB1, for treatment against epithelial ovarian cancer (EOC).

28 Sep 2017

Researchers discover new class of molecules that may protect brain from injury or diseases

Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans, has discovered a new class of molecules in the brain that synchronize cell-to-cell communication and neuroinflammation/immune activity in response to injury or diseases.

28 Sep 2017

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

Cancers driven by mutations in the KRAS gene are among the most deadly. For decades, researchers have tried unsuccessfully to directly target mutant KRAS proteins as a means to treat tumors.

28 Sep 2017

Rogue messengers can negatively affect the body's immune system response against cancer

Researchers from Trinity College Dublin have made a discovery around treatment-resistant breast cancer that may turn the phrase, 'don't shoot the messenger', on its head. The scientists have found that cell to cell messengers released by cancer cells which are not responding to treatment, can negatively affect the body's immune system response against cancer.

28 Sep 2017

Blood test may predict treatment outcomes for patients with localized NSCLC

A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized non-small cell lung cancer (NSCLC) and afford physicians additional lead time to personalize treatment for recurrent disease.

28 Sep 2017

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

27 Sep 2017

High-speed method generates mini-protein binders with potential to become new class of drugs

Scientists have created a high-speed method to generate thousands of different, small, stable proteins from scratch that can be custom-designed to bind to specific therapeutic targets.

27 Sep 2017

Researchers provide new insights into vertebrae formation

Like a string of pearls, the spine is made of a series of similar vertebrae. A so-called segmentation clock creates this repetitive arrangement in developing embryos: Each time the clock ticks, a vertebra starts to form.

27 Sep 2017

Plant substance shows inhibitory effects on cancer stem cells

The plant Ambrosia arborescens grows at a high elevation in large parts of South America, and is traditionally used as a medicinal plant. The researchers have isolated the sesquiterpene lactone damsin from the plant and studied its effect on cancer stem cells in three different breast cancer cell lines.

27 Sep 2017

Researchers explore what happens during break down of nerve cells

A stroke is just one example of a condition when communication between nerve cells breaks down. Micro-failures in brain functioning also occur in conditions such as depression and dementia. In most cases, the lost capacity will return after a while.

27 Sep 2017

Penn researchers develop predictive model to help lung cancer patients avoid ED visits

A pilot program that uses big data to predict which lung cancer patients will require a trip to an emergency department successfully anticipated a third of all ED visits over a two-week trial period, and was further able to identify which patients were at high risk and low risk of requiring such care.

27 Sep 2017

IMB researchers unveil mystery of aging process

Researchers at the Institute of Molecular Biology in Mainz have made a breakthrough in understanding the origin of the aging process. They have identified that genes belonging to a process called autophagy, which is one of the cells most critical survival processes, promote health and fitness in young worms but drive the process of aging later in life.

27 Sep 2017

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Merck KGaA, Darmstadt, Germany, and Pfizer Inc. today announced that the Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved BAVENCIO (avelumab, genetically recombinant Injection 200mg/mL for intravenous use) as the first and only treatment indicated for curatively unresectable Merkel cell carcinoma (MCC), a rare and aggressive cancer, in Japan.

27 Sep 2017

B Cell News and Research

Deep Genomics receives $13 million investment to create new class of genetic drugs

Surgical screws being developed from donated human bone material

DuraClone RE antibody panels improve detection of rare, abnormal events in blood disorders

Researchers test way to stop or slow cardiac fibrosis after heart injury

Drug approved to treat parasitic infections also exerts anti-tumor effect on EOC cells

Researchers discover new class of molecules that may protect brain from injury or diseases

Gene editing technique helps uncover potential new drug targets for KRAS-driven cancers

Rogue messengers can negatively affect the body's immune system response against cancer

Blood test may predict treatment outcomes for patients with localized NSCLC

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

High-speed method generates mini-protein binders with potential to become new class of drugs

Researchers provide new insights into vertebrae formation

Plant substance shows inhibitory effects on cancer stem cells

Researchers explore what happens during break down of nerve cells

Penn researchers develop predictive model to help lung cancer patients avoid ED visits

IMB researchers unveil mystery of aging process

First-ever treatment for Merkel cell carcinoma receives approval in Japan

Understanding molecular mechanisms and metabolic pathways of yeast for drug discovery

Cellular messaging mechanism could lead to new way of treating disease

Trial identifies genetic fault that affects treatment response in leukemia patients

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News